Pasar al contenido principal

RED DE CRISTALOGRAFIA Y CRISTALIZACION "FACTORIA DE CRISTALIZACION"

FIS2015-71928-REDC

•
Nombre agencia financiadora Ministerio de Economía y Competitividad
Acrónimo agencia financiadora MINECO
Programa Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Redes Investigación /Redes Excelencia
Año convocatoria 2015
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Unidad de gestión Secretaría de Estado de Investigación, Desarrollo e Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)
Identificador persistente http://dx.doi.org/10.13039/501100003329

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

Knowledge-bases prediction of multicomponent forms of nevirapine

  • Costa, R. N.
  • Choquesillo-Lazarte, Duane
  • Infantes, Lourdes
  • Pidcock, Elna
  • Cuffini, Silvia L.
LACA 2019, Bucaramanga, Colombia, October 7th-10th, 2019. -- https://ivlaca2019.co/, Nevirapine (NVP), an antiretroviral drug used in AIDS/HIV treatment [1], is a class II drug, according to the Biopharmaceutical Classification System (BCS) [2], presenting low solubility and high permeability. The low solubility leads to formulation difficulties and a considerable decrease in the bioavailability. A strategy to improve physicochemical properties, including the solubility, is the preparation of modified crystals of NVP. A crystalline modification frequently used is based on the inclusion of other molecules in the drug crystalline structure, forming multicomponent structures. NVP presents a rigid amide group and it is expected an NVP-co-former interaction in this point [3]. Among the possible multicomponent structures are the cocrystals, salts, solvates and eutectic systems. The process to obtain multicomponent crystalline forms of a drug could be an expensive and long-term process, since there is an infinity of possible co-former molecules [4]. So, it is necessary to optimize and to rationalize the co-formers selection using knowledge-based supramolecular chemistry. This work proposes a rational strategy in the design of the crystalline modifications based on the utilization of statistic tools developed by the Cambridge Crystallographic Data Centre (CCDC) [5], in order to predict the molecular complementarity between NVP and other molecular entities [6-8]. The prediction method validation is obtained through the preparation of multicomponent solids (solvates, cocrystals and eutectic systems) using a variety of crystallization techniques. The materials are characterized by X-ray diffraction, thermal analysis, optical microscope, Raman spectroscopy and, solid-state nuclear magnetic resonance spectroscopy, This work was supported by Coordenação de Aperfeiçoamento de Pessoal de Nível Superior – Brasil (CAPES) – Finance Code 001, Consejo Superior de Investigaciones Científicas (CSIC) (i-COOP+2015, COOPA20094) and Red de Cristalografía y Cristalización “Factoría de Cristalizacion” (FIS2015-71928-REDC).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

Novel solid forms of an antiretroviral drug: solvates, cocrystals and eutectic systems

  • Costa, R. N.
  • Choquesillo-Lazarte, Duane
  • Infantes, Lourdes
  • Cuffini, Silvia L.
LACA 2019, Bucaramanga, Colombia, October 7th-10th, 2019. -- https://ivlaca2019.co/, Nevirapine (11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one) (NVP) is an antiretroviral used to treat HIV-1 infection [1]. According to the Biopharmaceutical Classification System (BCS) [2], NVP is classified as a class II drug [3], which means it presents low solubility and high permeability. The low solubility implies in problems during formulation and resulting in a decreasing in the bioavailability. Solid-state modifications have been used in pharmaceutical area as a strategy to improve drug properties. Among the possible modifications there is the formation of multicomponent forms, including cocrystals, solvates and eutectic systems (figure 1). Several multicomponent structures containing the NVP have been described in literature. In a screening of new multicomponent forms of NVP, four co-crystals, five solvates and two eutectic systems have been found. Characterization of materials were performed using optical microscopy, powder X-ray diffraction (PXRD), differential scanning calorimetry (DSC) and Raman spectroscopy. Crystalline structures were determined single X-ray diffraction (SXRD) data., This work was supported by Coordenação de Aperfeiçoamento de Pessoal de Nível Superior – Brasil (CAPES) – Finance Code 001, Consejo Superior de Investigaciones Científicas (CSIC) (i-COOP+2015, COOPA20094) and Red de Cristalografía y Cristalización “Factoría de Cristalizacion” (FIS2015-71928-REDC).